{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:25:14Z","timestamp":1774682714272,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4414,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1046\/j.1523-1747.2003.12565.x","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T16:08:24Z","timestamp":1068134904000},"page":"1060-1065","source":"Crossref","is-referenced-by-count":50,"title":["Thalidomide Inhibits Tumor Necrosis Factor-\u03b1 Production and Antigen Presentation by Langerhans Cells"],"prefix":"10.1016","volume":"121","author":[{"given":"Liang","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Granstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"0","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0015","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0190-9622(84)80458-2","article-title":"Studies on the anti-inflammatory properties of thalidomide: Effects on polymorphonuclear leukocytes and monocytes","volume":"11","author":"Barnhill","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/360258a0","article-title":"GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells","volume":"360","author":"Caux","year":"1992","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0025","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","article-title":"Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha","volume":"163","author":"Corral","year":"1999","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"10.1046\/j.1523-1747.2003.12565.x_bb0030","doi-asserted-by":"crossref","first-page":"I107","DOI":"10.1136\/ard.58.2008.i107","article-title":"Immunomodulation by thalidomide and thalidomide analogues","volume":"58","author":"Corral","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0035","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1365-2133.1999.02964.x","article-title":"Tumour necrosis factor-alpha induces Langerhans cell migration in humans","volume":"141","author":"Cumberbatch","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0040","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0045","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archderm.135.9.1079","article-title":"American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus","volume":"135","author":"Duong","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00406421","article-title":"Inhibition of PMN leukocytes chemotaxis by thalidomide","volume":"269","author":"Faure","year":"1980","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0055","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1200\/JCO.2000.18.4.708","article-title":"Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas","volume":"18","author":"Fine","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/1523-1747.ep12277165","article-title":"Direct effects of glucocorticosteroids on epidermal Langerhans cells","volume":"92","author":"Furue","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0065","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.4049\/jimmunol.140.12.4139","article-title":"The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro","volume":"140","author":"Furue","year":"1988","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0167-5699(95)80125-1","article-title":"Dendritic cells as initiators of tumor immune response: A possible strategy for tumor immunotherapy?","volume":"16","author":"Grabbe","year":"1995","journal-title":"Immunol Today"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jlb.52.2.209","article-title":"Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: Modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation","volume":"52","author":"Grabbe","year":"1992","journal-title":"J Leukoc Biol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0080","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.4049\/jimmunol.155.9.4207","article-title":"Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity","volume":"155","author":"Grabbe","year":"1995","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0085","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.4049\/jimmunol.138.12.4055","article-title":"Epidermal cells in activation of suppressor lymphocytes: Further characterization","volume":"138","author":"Granstein","year":"1987","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome: A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0095","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1084\/jem.187.11.1885","article-title":"Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine pro-duction, and cytotoxic responses in the CD8+ subset","volume":"187","author":"Haslett","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/282324a0","article-title":"Epidermal Langerhans cells are derived from cells originating in bone marrow","volume":"282","author":"Katz","year":"1979","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI118759","article-title":"A novel mechanism of glucocorticoid-induced immune suppression: The inhibition of T cell-mediated terminal maturation of a murine dendritic cell line","volume":"98","author":"Kitajima","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0002-9343(88)90576-1","article-title":"Elevated levels of circulating cachectin\/tumor necrosis factor in patients with acquired immunodeficiency syndrome","volume":"85","author":"Lahdevirta","year":"1988","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0115","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0167-5699(99)01531-5","article-title":"Thalidomide as an emerging immunotherapeutic agent","volume":"20","author":"Marriott","year":"1999","journal-title":"Immunol Today"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0120","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.4049\/jimmunol.161.8.4236","article-title":"CC-3052: A water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production","volume":"161","author":"Marriott","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0125","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/eji.1830230730","article-title":"Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells","volume":"23","author":"Moll","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0130","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/clinids\/20.2.250","article-title":"Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection","volume":"20","author":"Paterson","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/aid.1992.8.191","article-title":"The effect of cytokines and pharmacologic agents on chronic HIV infection","volume":"8","author":"Poli","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0145","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn's disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0150","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1084\/jem.151.2.362","article-title":"Role of antigen-presenting cells in the development and persistence of contact hypersensitivity","volume":"151","author":"Ptak","year":"1980","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0155","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/168.2.408","article-title":"The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum","volume":"168","author":"Sampaio","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0160","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0165","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1084\/jem.161.3.526","article-title":"Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro","volume":"161","author":"Schuler","year":"1985","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the treatment of lepra reactions","volume":"6","author":"Sheskin","year":"1965","journal-title":"Clin Pharmacol Ther"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0175","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.4049\/jimmunol.133.4.2067","article-title":"Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen","volume":"133","author":"Shimonkevitz","year":"1984","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0180","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4049\/jimmunol.145.7.2087","article-title":"Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset","volume":"145","author":"Simon","year":"1990","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0185","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma","volume":"341","author":"Singhal","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0190","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4049\/jimmunol.121.5.2005","article-title":"Immunologic functions of Ia-bearing epidermal Langerhans cells","volume":"121","author":"Stingl","year":"1978","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0195","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4049\/jimmunol.127.4.1707","article-title":"Antigen presentation by murine epi-dermal langerhans cells and its alteration by ultraviolet B light","volume":"127","author":"Stingl","year":"1981","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0200","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.4049\/jimmunol.137.8.2460","article-title":"Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells","volume":"137","author":"Sullivan","year":"1986","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0205","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2133.1991.tb14163.x","article-title":"Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells","volume":"125","author":"Teunissen","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0210","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF03401576","article-title":"Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis","volume":"1","author":"Tramontana","year":"1995","journal-title":"Mol Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0215","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0190-9622(96)90122-X","article-title":"Rediscovering thalidomide. A review of its mechanism of action, side effects, and potential uses","volume":"35","author":"Tseng","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0220","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM199204163261604","article-title":"Thalidomide for the treatment of chronic graft-versus-host disease","volume":"326","author":"Vogelsang","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0225","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.4049\/jimmunol.159.12.6148","article-title":"Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75","volume":"159","author":"Wang","year":"1997","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0230","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.4049\/jimmunol.154.6.2697","article-title":"Successive generation of antigen-presenting dendritic cell lines from murine epidermis","volume":"154","author":"Xu","year":"1995","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12565.x_bb0235","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/eji.1830250424","article-title":"Cytokine-dependent regulation of growth and maturation in murine epidermal dendritic cell lines","volume":"25","author":"Xu","year":"1995","journal-title":"Eur J Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15304978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15304978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:28:45Z","timestamp":1704961725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15304978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0022202X15304978"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2003.12565.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}